Literature DB >> 23720790

Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum.

Norbert P LeClair1, Melissa D Conrad, Frederick N Baliraine, Christian Nsanzabana, Samuel L Nsobya, Philip J Rosenthal.   

Abstract

Genetic polymorphisms in the malaria parasite Plasmodium falciparum mediate alterations in sensitivity to important antimalarial drugs. Surveillance for these polymorphisms is helpful in assessing the prevalence of drug resistance and designing strategies for malaria control. Multiple methods are available for the assessment of P. falciparum genetic polymorphisms, but they suffer from low throughput, technical limitations, and high cost. We have optimized and tested a multiplex ligase detection reaction-fluorescent microsphere (LDR-FM) assay for the identification of important P. falciparum genetic polymorphisms. For 84 clinical samples from Kampala, Uganda, a region where both transmission intensity and infection complexity are high, DNA was extracted from dried blood spots, genes of interest were amplified, amplicons were subjected to multiplex ligase detection reactions to add bead-specific oligonucleotides and biotin, fragments were hybridized to magnetic beads, and polymorphism prevalences were assessed fluorometrically in a multiplex format. A total of 19 alleles from the pfcrt, pfmdr1, pfmrp1, pfdhfr, and pfdhps genes were analyzed by LDR-FM and restriction fragment length polymorphism (RFLP) analyses. Considering samples with results from the two assays, concordance between the assays was good, with 78 to 100% of results identical at individual alleles, most nonconcordant results differing only between a mixed and pure genotype call, and full disagreement at individual alleles in only 0 to 3% of results. We estimate that the LDR-FM assay offers much higher throughput and lower cost than RFLP. Our results suggest that the LDR-FM system offers an accurate high-throughput means of classifying genetic polymorphisms in field samples of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23720790      PMCID: PMC3719660          DOI: 10.1128/JCM.00904-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Evidence of artemisinin-resistant malaria in western Cambodia.

Authors:  Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

2.  Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.

Authors:  Anyirékun Fabrice Somé; Yves Y Séré; Christian Dokomajilar; Issaka Zongo; Noël Rouamba; Bryan Greenhouse; Jean-Bosco Ouédraogo; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

3.  In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.

Authors:  Leah Mwai; Steven M Kiara; Abdi Abdirahman; Lewa Pole; Anja Rippert; Abdi Diriye; Pete Bull; Kevin Marsh; Steffen Borrmann; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

4.  Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.

Authors:  Fatima Nawaz; Samuel L Nsobya; Moses Kiggundu; Moses Joloba; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

5.  Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum.

Authors:  Frédérique de Monbrison; Delphine Raynaud; Christine Latour-Fondanaiche; Anne Staal; Sébastien Favre; Karine Kaiser; François Peyron; Stéphane Picot
Journal:  J Microbiol Methods       Date:  2003-09       Impact factor: 2.363

6.  Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance.

Authors:  Anne F Gasasira; Moses R Kamya; Edwin O Ochong; Neil Vora; Jane Achan; Edwin Charlebois; Theodore Ruel; Fredrick Kateera; Denise N Meya; Diane Havlir; Philip J Rosenthal; Grant Dorsey
Journal:  Malar J       Date:  2010-06-23       Impact factor: 2.979

7.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

8.  Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa.

Authors:  Sabina Dahlström; Pedro E Ferreira; M Isabel Veiga; Nazli Sedighi; Lisa Wiklund; Andreas Mårtensson; Anna Färnert; Christin Sisowath; Lyda Osório; Hamid Darban; Björn Andersson; Akira Kaneko; Gwenaëlle Conseil; Anders Björkman; J Pedro Gil
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

9.  Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.

Authors:  Amadou T Konaté; Jean Baptiste Yaro; Amidou Z Ouédraogo; Amidou Diarra; Adama Gansané; Issiaka Soulama; David T Kangoyé; Youssouf Kaboré; Espérance Ouédraogo; Alphonse Ouédraogo; Alfred B Tiono; Issa N Ouédraogo; Daniel Chandramohan; Simon Cousens; Paul J Milligan; Sodiomon B Sirima; Brian Greenwood; Diadier A Diallo
Journal:  PLoS Med       Date:  2011-02-01       Impact factor: 11.069

10.  Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.

Authors:  Tamara D Clark; Denise Njama-Meya; Bridget Nzarubara; Catherine Maiteki-Sebuguzi; Bryan Greenhouse; Sarah G Staedke; Moses R Kamya; Grant Dorsey; Philip J Rosenthal
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more
  25 in total

1.  Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.

Authors:  Erika Wallender; Nan Zhang; Melissa Conrad; Abel Kakuru; Mary Muhindo; Patrick Tumwebaze; Richard Kajubi; Daniel Mota; Jennifer Legac; Prasanna Jagannathan; Diane Havlir; Moses Kamya; Grant Dorsey; Francesca Aweeka; Philip J Rosenthal; Rada M Savic
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.

Authors:  Patrick Tumwebaze; Stephen Tukwasibwe; Aimee Taylor; Melissa Conrad; Emmanuel Ruhamyankaka; Victor Asua; Andrew Walakira; Joaniter Nankabirwa; Adoke Yeka; Sarah G Staedke; Bryan Greenhouse; Samuel L Nsobya; Moses R Kamya; Grant Dorsey; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

3.  Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular Assays.

Authors:  Roland A Cooper; Melissa D Conrad; Quentin D Watson; Stephanie J Huezo; Harriet Ninsiima; Patrick Tumwebaze; Samuel L Nsobya; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

4.  Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.

Authors:  Joaniter I Nankabirwa; Melissa D Conrad; Jennifer Legac; Stephen Tukwasibwe; Patrick Tumwebaze; Bonnie Wandera; Simon J Brooker; Sarah G Staedke; Moses R Kamya; Sam L Nsobya; Grant Dorsey; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children.

Authors:  Melissa D Conrad; Norbert LeClair; Emmanuel Arinaitwe; Humphrey Wanzira; Abel Kakuru; Victor Bigira; Mary Muhindo; Moses R Kamya; Jordan W Tappero; Bryan Greenhouse; Grant Dorsey; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

6.  Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.

Authors:  Adoke Yeka; Erika Wallender; Ronald Mulebeke; Afizi Kibuuka; Ruth Kigozi; Agaba Bosco; Paul Kyambadde; Jimmy Opigo; Simeon Kalyesubula; Joseph Senzoga; Joanna Vinden; Melissa Conrad; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2019-03-15       Impact factor: 5.226

7.  Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.

Authors:  Silvie Huijben; Brian H K Chan; Andrew F Read
Journal:  Am J Trop Med Hyg       Date:  2015-05-04       Impact factor: 2.345

8.  Changing Antimalarial Drug Sensitivities in Uganda.

Authors:  Stephanie A Rasmussen; Frida G Ceja; Melissa D Conrad; Patrick K Tumwebaze; Oswald Byaruhanga; Thomas Katairo; Samuel L Nsobya; Philip J Rosenthal; Roland A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

9.  Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.

Authors:  George W Mbogo; Sheila Nankoberanyi; Stephen Tukwasibwe; Frederick N Baliraine; Samuel L Nsobya; Melissa D Conrad; Emmanuel Arinaitwe; Moses Kamya; Jordan Tappero; Sarah G Staedke; Grant Dorsey; Bryan Greenhouse; Philip J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2014-05-05       Impact factor: 2.345

10.  Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.

Authors:  Patrick Tumwebaze; Melissa D Conrad; Andrew Walakira; Norbert LeClair; Oswald Byaruhanga; Christine Nakazibwe; Benjamin Kozak; Jessica Bloome; Jaffer Okiring; Abel Kakuru; Victor Bigira; James Kapisi; Jennifer Legac; Jiri Gut; Roland A Cooper; Moses R Kamya; Diane V Havlir; Grant Dorsey; Bryan Greenhouse; Samuel L Nsobya; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.